Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Soichi Hirai"'
Autor:
Ryota Nakamura, Tadaaki Yamada, Satomi Tanaka, Aosa Sasada, Shinsuke Shiotsu, Nozomi Tani, Takayuki Takeda, Yusuke Chihara, Soichi Hirai, Yoshizumi Takemura, Akihiro Yoshimura, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Young Hak Kim, Koichi Takayama
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9097-9105 (2023)
Abstract Background Lung cancer patients face a high risk of thromboembolism (TE), which is considered to be a poor prognostic factor. However, the impact of symptomatic cerebral infarction (CI) and pulmonary embolism (PE) on the prognosis of advance
Externí odkaz:
https://doaj.org/article/69b2b1be97d84bcea46fd2c77252efe8
Autor:
Yuki Katayama, Tadaaki Yamada, Keiko Tanimura, Shinsaku Tokuda, Kenji Morimoto, Soichi Hirai, Yohei Matsui, Ryota Nakamura, Masaki Ishida, Hayato Kawachi, Kazue Yoneda, Kazutaka Hosoya, Takahiro Tsuji, Hiroaki Ozasa, Akihiro Yoshimura, Masahiro Iwasaku, Young Hak Kim, Mano Horinaka, Toshiyuki Sakai, Takahiro Utsumi, Shinsuke Shiotsu, Takayuki Takeda, Ryohei Katayama, Koichi Takayama
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitors rarely elicit complete responses in patients with advanced ALK-rearranged non-small cell lung cancer (NSCLC), as a small population of tumor cells survives due to adaptive resistanc
Externí odkaz:
https://doaj.org/article/583207af794a452d86780039dd00b9de
Autor:
Tadaaki Yamada, Soichi Hirai, Yuki Katayama, Akihiro Yoshimura, Shinsuke Shiotsu, Satoshi Watanabe, Toshiaki Kikuchi, Kazuki Hirose, Yutaka Kubota, Yusuke Chihara, Taishi Harada, Keiko Tanimura, Takayuki Takeda, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1521-1529 (2019)
Abstract Background Treatment with epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) leads to initial response in most patients with EGFR‐mutated non‐small cell lung cancer (NSCLC). In contrast, little is known of the su
Externí odkaz:
https://doaj.org/article/6018c2c492604e2d9a105d52498c1361
Autor:
Makoto, Hibino, Kiyoaki, Uryu, Takayuki, Takeda, Yusuke, Kunimatsu, Shinsuke, Shiotsu, Junji, Uchino, Soichi, Hirai, Tadaaki, Yamada, Asuka, Okada, Yoshikazu, Hasegawa, Osamu, Hiranuma, Yusuke, Chihara, Riko, Kamada, Shunichi, Tobe, Kazunari, Maeda, Shigeto, Horiuchi, Tetsuri, Kondo, Koichi, Takayama
Publikováno v:
Journal of Thoracic Oncology. 17:1002-1013
Patients with cancer have been prioritized for vaccination against severe acute respiratory syndrome coronavirus 2. Nevertheless, there are limited data regarding the safety, efficacy, and risk of developing immune-related adverse events (irAEs) asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212b776c9279a0d36946d9ddc005f3a1
https://doi.org/10.1016/j.jtho.2022.05.015
https://doi.org/10.1016/j.jtho.2022.05.015
Autor:
Naoya Nishioka, Tadaaki Yamada, Sachi Harita, Soichi Hirai, Yuki Katayama, Takayuki Nakano, Naoko Okura, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Publikováno v:
Respiratory Medicine Case Reports, Vol 25, Iss , Pp 261-263 (2018)
NSCLC patients with EGFR mutations respond to EGFR-TKIs; however, the management of refractory tumors to EGFR-TKIs remains unclear. We demonstrated that repeated genetic testing might be useful for detecting resistance mechanisms as well as for decis
Externí odkaz:
https://doaj.org/article/d705d98636954eb59fb21331b1d74aae
Autor:
Shinsuke Shiotsu, Yusuke Chihara, Akihiro Yoshimura, Yutaka Kubota, Koichi Takayama, Nobuyo Tamiya, Yoshiko Kaneko, Takayuki Takeda, Keiko Tanimura, Soichi Hirai, Tadaaki Yamada, Taishi Harada, Kazuki Hirose, Toshiaki Kikuchi, Junji Uchino, Satoshi Watanabe, Yuki Katayama
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1521-1529 (2019)
Cancer Medicine
Cancer Medicine
Background Treatment with epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) leads to initial response in most patients with EGFR‐mutated non‐small cell lung cancer (NSCLC). In contrast, little is known of the subpopulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5b4bcf9b850b44ed1afbab6ce8bae2
https://doaj.org/article/6018c2c492604e2d9a105d52498c1361
https://doaj.org/article/6018c2c492604e2d9a105d52498c1361
Autor:
Soichi Hirai, Naoko Okura, Satomi Tanaka, Sayaka Uda, Takayuki Shimamoto, Yoshiko Kaneko, Takayuki Takeda, Shinsuke Shiotsu, Koichi Takayama, Keiko Tanimura, Masahiro Iwasaku, Yusuke Chihara, Taishi Harada, Kazuki Hirose, Tadaaki Yamada, Junji Uchino, Yuki Katayama, Osamu Hiranuma
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Cancer immunotherapy, including atezolizumab monotherapy, is a promising alternative strategy for patients with advanced non-small-cell lung cancer (NSCLC). Several inflammatory indices have been reported as potential biomarkers regarding the effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4f8bd09b9fc7480218aea4d9725a4d
http://europepmc.org/articles/PMC7566597
http://europepmc.org/articles/PMC7566597
Autor:
Yuki Katayama, Naoya Nishioka, Nobuyo Tamiya, Takayuki Nakano, Naoko Okura, Tadaaki Yamada, Sachi Harita, Yoshiko Kaneko, Junji Uchino, Soichi Hirai, Koichi Takayama
Publikováno v:
Respiratory Medicine Case Reports, Vol 25, Iss, Pp 261-263 (2018)
Respiratory Medicine Case Reports
Respiratory Medicine Case Reports
NSCLC patients with EGFR mutations respond to EGFR-TKIs; however, the management of refractory tumors to EGFR-TKIs remains unclear. We demonstrated that repeated genetic testing might be useful for detecting resistance mechanisms as well as for decis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1640181054d0ecf6ebc231bb26eed2
http://www.sciencedirect.com/science/article/pii/S2213007118302703
http://www.sciencedirect.com/science/article/pii/S2213007118302703
Autor:
Tadaaki Yamada, Soichi Hirai, Akihiro Yoshimura, Satoshi Watanabe, Junji Uchino, Koichi Takayama
Publikováno v:
Cancer Research. 79:4036-4036
Background The treatment with EGFR-TKIs leads to initial response in most patients with EGFR mutated non-small cell lung cancer (NSCLC). In contrast, little is known the subpopulation of NSCLC patients with EGFR mutations who had clinical outcomes to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2849c63eeb19f9d68d7bc3cd4529eef3
https://doi.org/10.1158/1538-7445.am2019-4036
https://doi.org/10.1158/1538-7445.am2019-4036
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
Autor:
Tatsuya Imabayashi, Keiko Tanimura, Nobuyo Tamiya, Naoko Okura, Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Akihiro Yoshimura, Sachi Harita, Junji Uchino, Naoya Nishioka, Yoshiko Kaneko, Yusuke Chihara, Koichi Takayama
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 8, Iss 4, p 450 (2019)
Volume 8
Issue 4
Journal of Clinical Medicine, Vol 8, Iss 4, p 450 (2019)
Volume 8
Issue 4
Secondary sarcopenia is defined as a decrease in muscle mass due to disease or malnutrition. Several studies have reported that secondary sarcopenia is an indicator of postoperative recurrence. We hypothesized that there is a correlation between the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e513c954622f5501f93f91ced2497e71
https://doi.org/10.3390/jcm8040450
https://doi.org/10.3390/jcm8040450